ESC 365 - Role of surgery for aortic valve treatment in the era of TAVR

ESC Professional Premium Access

Role of surgery for aortic valve treatment in the era of TAVR

Session: Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies

Topic: Valvular Heart Disease

Speaker: Professor S. Bleiziffer (Bad Berka, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Sabine Bleiziffer

Heart Centre Central Clinic Bad Berka, Bad Berka (Germany)

10 presentations

0 follower

10 more presentations in this session

Introduction

Considerations for lifetime management of aortic stenosis

Speaker: Doctor A. Gupta (Los Angeles, US)

The future of aortic valve intervention: asymptomatic aortic stenosis, moderate aortic stenosis, bicuspid aortic stenosis, aortic insufficiency

Speaker: Professor H. Eltchaninoff (Rouen, FR)

Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies - panel discussion 1

Transcatheter mitral valve therapies: overcoming hurdles, seizing opportunities

Speaker: Doctor R. Makkar (Los Angeles, US)

Access the full session

Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies

Speakers: Professor S. Bleiziffer, Doctor A. Gupta, Professor H. Eltchaninoff, Doctor R. Makkar

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources

novartis

Explore sponsored resources